Pharmaceutical-grade
compounds, engineered
in Austin, Texas.
Arexium operates under a state-licensed compounding laboratory dedicated to next-generation peptide therapeutics. Every formulation is prepared under USP <797> sterile protocols, batch-verified for identity and purity, and dispatched the following business day.
Compounded in-house
Every vial originates from our licensed Austin, TX facility — never outsourced, never re-labeled.
Overnight delivery
Every order ships via FedEx Priority Overnight® the next business day, with cold-chain packaging and full tracking.
Third-party verified
Each lot is independently tested by ISO-accredited laboratories. Certificates available upon request.
Cold-chain integrity
Temperature-controlled packaging with thermal validation ensures stability from lab to door.
Three therapeutics.
One standard.
Our incretin-mimetic line represents three generations of metabolic research, each formulated to the same uncompromising specification. Selection should be made in consultation with a licensed practitioner.
GLP — IS
A long-acting glucagon-like peptide-1 analogue formulated for once-weekly subcutaneous administration. The most extensively characterized incretin-mimetic in modern metabolic science, supporting glycemic regulation and appetite modulation through native receptor pathways.
10mg vial
Reconstituted
6 months
GLP — IIT
A second-generation co-agonist engaging both glucose-dependent insulinotropic polypeptide and GLP-1 receptors simultaneously. The dual-pathway architecture is associated with enhanced metabolic efficacy and refined satiety modulation across clinical investigation.
10mg vial
Reconstituted
6 months
GLP — IIIR
The most advanced therapeutic in the catalog: a triple-agonist activating GIP, GLP-1, and glucagon receptors in concert. Currently the subject of leading-edge clinical trials, this molecule represents the present frontier of incretin-based metabolic intervention.
10mg vial
Reconstituted
6 months
Purity is not
a marketing claim.
It is the foundational specification of every compound we release. Purity is documented, traceable, and independently verified — not asserted.
-
i.
HPLC-Verified Purity ≥ 99%
Every batch is analyzed by reverse-phase high-performance liquid chromatography. We do not release lots below a 99% purity threshold — and we publish the exact figure on every Certificate of Analysis.
-
ii.
Pharmaceutical-grade raw materials
All active peptides are sourced from FDA-registered facilities that specialize in pharmaceutical-grade synthesis. Mass spectrometry and amino-acid analysis confirm structural identity prior to compounding.
-
iii.
ISO Class 5 sterile environment
Compounding is performed within a certified ISO Class 5 laminar-flow workspace. Environmental monitoring, gowning protocols, and media-fill validation are conducted on a continuous schedule.
-
iv.
Third-party endotoxin testing
Each lot undergoes independent LAL endotoxin and sterility testing through ISO 17025-accredited laboratories. Test results are available on request, referenced by lot number.
-
v.
Validated cold-chain logistics
Vials are dispatched in temperature-mapped insulated packaging with validated phase-change media, ensuring formulation stability from our facility to your residence.
An ordered process,
executed in under 48 hours.
Order placed
Health intake reviewed where applicable. Order is logged into the production queue with a unique lot identifier.
Compounded
Reconstitution and lyophilization performed within our ISO 5 cleanroom by licensed compounding personnel.
Verified & sealed
Each vial is visually inspected, lot-stamped, and accompanied by the corresponding Certificate of Analysis.
Dispatched
Cold-chain shipment leaves Austin the following business day with overnight tracking. Discreet packaging.